ETON Latest Headlines

Wall Street Analysts Are Bullish on Top Healthcare Picks

at www.tipranks.com (Thu, 15-Oct 7:30 AM)

Eton: LIBERVANT Deal Supports Neurology Franchise Growth; Buy Rating Reiterated with Unchanged $70 Price Target

at www.tipranks.com (Wed, 14-Oct 12:55 PM)

Aquestive rises on licensing deal with Eton for antiseizure therapy

at seekingalpha.com (Wed, 14-Oct 8:03 AM)

Eton Pharmaceuticals Secures LIBERVANT U.S. Licensing Agreement

at www.tipranks.com (Wed, 14-Oct 7:48 AM)

Record Revenue and Higher Guidance Highlight Eton Pharmaceuticals’ Standout Quarter

Market Chameleon (Fri, 14-Aug 10:30 AM)

Eton Pharmaceuticals Doubles Revenue and Raises Guidance Amid Strong Rare Disease Portfolio Performance

Market Chameleon (Fri, 14-Aug 7:27 AM)